Can-Fite Biopharma Ltd (CANF) - NYSEMKT
  • Jun. 19, 2015, 7:43 AM
    • Can-Fite BioPharma (NYSEMKT:CANF) subsidiary OphthaliX acquires Israel-based Improved Vision Systems Ltd. (IVS) in an all-stock deal. OphthaliX will issue shares and options equal to an aggregate of 14% of its outstanding stock on a fully diluted basis plus additional shares and options equal to 11% of OphthaliX's outstanding shares upon the achievement of certain milestones. No Can-Fite shares will be issued in the transaction.
    • IVS is developing two products: an indoor eye tracking device that attaches to a TV or computer screen that manipulates the image to best compensate for the viewer's specific clinical impairment and a goggles-based mobile device which generates high definition displays that are manipulated and moved in sync with the movement of each eye, thus restoring mobility and independence of visually impaired people.
    • OphthaliX's lead product candidate is CF101, a neuro-protective and anti-inflammatory drug for the treatment of glaucoma.
    | Jun. 19, 2015, 7:43 AM
  • May 4, 2015, 10:36 AM
    • Can-Fite BioPharma (CANF) subsidiary OphthaliX (OTCPK:OPLI) signs a non-binding term sheet to acquire Israel-based Improved Vision Systems, a developer of devices to improve sight. It is focused on two types of products: 1) an indoor eye tracking solution which can be attached to a TV, computer screen, etc. that manipulates the projected image in a way that best compensates for the user's clinical impairment and 2) a goggles-based mobile device that generates high definition displays that are manipulated and moved based on the movement of each eye, thereby enabling vision-impaired people to regain their independence and mobility.
    • The proposed financial terms are not disclosed.
    | May 4, 2015, 10:36 AM
Company Description
Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. It products include pipeline drugs such as CF101,... More
Sector: Healthcare
Industry: Biotechnology
Country: Israel